Viewing Study NCT01625156


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-04 @ 3:42 AM
Study NCT ID: NCT01625156
Status: COMPLETED
Last Update Posted: 2015-10-20
First Post: 2012-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-05
Start Date Type: None
Primary Completion Date: 2015-09
Primary Completion Date Type: ACTUAL
Completion Date: 2015-10
Completion Date Type: ACTUAL
First Submit Date: 2012-06-18
First Submit QC Date: None
Study First Post Date: 2012-06-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-10-19
Last Update Post Date: 2015-10-20
Last Update Post Date Type: ESTIMATED